What does WILLEM SCHURMANS, CARDIOLOGIE do?

WILLEM SCHURMANS, CARDIOLOGIE is a specialist medical practice in Holsbeek. Private Limited, started on 5 August 2019, 1 establishment.

What is the address of WILLEM SCHURMANS, CARDIOLOGIE?

The registered office of WILLEM SCHURMANS, CARDIOLOGIE is located at Meesberg 52, 3220 Holsbeek.

Is WILLEM SCHURMANS, CARDIOLOGIE still active?

Yes. According to the CBE (17 September 2026) WILLEM SCHURMANS, CARDIOLOGIE is active, legal situation “Normale toestand”, started on 5 August 2019.

Is WILLEM SCHURMANS, CARDIOLOGIE registered on Peppol?

Yes, WILLEM SCHURMANS, CARDIOLOGIE is registered on the Peppol network with ID 0208:0731844610.

What is the enterprise number of WILLEM SCHURMANS, CARDIOLOGIE?

The enterprise number of WILLEM SCHURMANS, CARDIOLOGIE is BE0731844610.

When was WILLEM SCHURMANS, CARDIOLOGIE founded?

WILLEM SCHURMANS, CARDIOLOGIE was founded on 5 August 2019.

Who are the directors of WILLEM SCHURMANS, CARDIOLOGIE?

According to the 2025 annual accounts, the directors of WILLEM SCHURMANS, CARDIOLOGIE are: Willem Schurmans.

Is WILLEM SCHURMANS, CARDIOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 August 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did WILLEM SCHURMANS, CARDIOLOGIE make in 2025?

WILLEM SCHURMANS, CARDIOLOGIE posted a profit after taxes of € 171,127 in financial year 2025.

What is the revenue of WILLEM SCHURMANS, CARDIOLOGIE?

As a small company, WILLEM SCHURMANS, CARDIOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 236,098.

WILLEM SCHURMANS, CARDIOLOGIE (Private Limited)

Dossier WILLEM SCHURMANS, CARDIOLOGIE, printed on 17 September 2026 from databakkes.be/en/0731844610/willem-schurmans-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 51 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

WILLEM SCHURMANS, CARDIOLOGIE from Holsbeek, company number BE0731844610, closed financial year 2025 with a result of € 171,127 after tax. For that financial year WILLEM SCHURMANS, CARDIOLOGIE recorded a gross margin of € 236,098 and equity of € 5,000. Compared with financial year 2024, the result moved from € 126,527 to € 171,127. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.

What it is worth Healthy

€ 5,000

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 171,127

▲ 35% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 68,831

▲ 12% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 171,127 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 22,723

▲ 106% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,250

▼ 9% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 22,399

▲ 3% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 105,851 Gross margin 2022: € 105,851 First fiscal year in the series	€ 144,663 Gross margin 2023: € 144,663 ▲ 37% vs 2022 (€ 105,851) Favourable step	€ 174,095 Gross margin 2024: € 174,095 ▲ 20% vs 2023 (€ 144,663) Favourable step	€ 236,098 Gross margin 2025: € 236,098 ▲ 36% vs 2024 (€ 174,095) Favourable step	▲ 36%
Profit after taxes	€ 79,445 Profit after taxes 2022: € 79,445 First fiscal year in the series	€ 107,271 Profit after taxes 2023: € 107,271 ▲ 35% vs 2022 (€ 79,445) Favourable step	€ 126,527 Profit after taxes 2024: € 126,527 ▲ 18% vs 2023 (€ 107,271) Favourable step	€ 171,127 Profit after taxes 2025: € 171,127 ▲ 35% vs 2024 (€ 126,527) Favourable step	▲ 35%
Equity	€ 5,000 Equity 2022: € 5,000 First fiscal year in the series	€ 5,000 Equity 2023: € 5,000 Unchanged (€ 5,000) Unchanged	€ 5,000 Equity 2024: € 5,000 Unchanged (€ 5,000) Unchanged	€ 5,000 Equity 2025: € 5,000 Unchanged (€ 5,000) Unchanged
Total debts	€ 224,966 Total debts 2022: € 224,966 First fiscal year in the series	€ 141,946 Total debts 2023: € 141,946 ▼ 37% vs 2022 (€ 224,966) Favourable step	€ 151,851 Total debts 2024: € 151,851 ▲ 7% vs 2023 (€ 141,946) Unfavourable step	€ 196,776 Total debts 2025: € 196,776 ▲ 30% vs 2024 (€ 151,851) Unfavourable step	▲ 30%
Cash	€ 158,802 Cash 2022: € 158,802 First fiscal year in the series	€ 26,084 Cash 2023: € 26,084 ▼ 84% vs 2022 (€ 158,802) Unfavourable step	€ 61,262 Cash 2024: € 61,262 ▲ 135% vs 2023 (€ 26,084) Favourable step	€ 68,831 Cash 2025: € 68,831 ▲ 12% vs 2024 (€ 61,262) Favourable step	▲ 12%
Dividend	€ 199,389 Dividend 2022: € 199,389 First fiscal year in the series	€ 107,271 Dividend 2023: € 107,271 ▼ 46% vs 2022 (€ 199,389) Unchanged	€ 126,527 Dividend 2024: € 126,527 ▲ 18% vs 2023 (€ 107,271) Unchanged	€ 171,127 Dividend 2025: € 171,127 ▲ 35% vs 2024 (€ 126,527) Unchanged	▲ 35%
Balance sheet total	€ 229,966 Balance sheet total 2022: € 229,966 First fiscal year in the series	€ 146,946 Balance sheet total 2023: € 146,946 ▼ 36% vs 2022 (€ 229,966) Unchanged	€ 156,851 Balance sheet total 2024: € 156,851 ▲ 7% vs 2023 (€ 146,946) Unchanged	€ 201,776 Balance sheet total 2025: € 201,776 ▲ 29% vs 2024 (€ 156,851) Unchanged	▲ 29%

Key figures of WILLEM SCHURMANS, CARDIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to WILLEM SCHURMANS, CARDIOLOGIE?

What happened at WILLEM SCHURMANS, CARDIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 22, 2026 New annual accounts for financial year 2025: profit of € 171,127 (▲ 35% vs 2024). Source: NBB ↗
Aug 5, 2019 New establishment in Holsbeek. KBO
2019 Willem Schurmans became a director. NBB
Aug 5, 2019 Start of the company according to the CBE. KBO

In short

From € 79,445 profit in 2022 to € 171,127 profit in 2025.

Paid € 150,071 in corporate taxes since 2022.

Best year ever: 2025, with € 171,127 profit.

Paid out € 604,313 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at WILLEM SCHURMANS, CARDIOLOGIE? We notify you, reason included.

Follow WILLEM SCHURMANS, CARDIOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Willem Schurmans

WILLEM SCHURMANS, CARDIOLOGIE

Behind WILLEM SCHURMANS, CARDIOLOGIE is Willem Schurmans.

See the full network in the app

Directors

According to the 2025 annual accounts

Willem Schurmans

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Meesberg 52

3220 Holsbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0731.844.610
VAT number: BE 0731.844.610
Registered office: Meesberg 52, 3220 Holsbeek
Names & denominations: WILLEM SCHURMANS, CARDIOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 August 2019
Peppol: Active · Active since 27 Oct 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗